HMPL-453

· Hutchison Medipharma Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HMPL-453, covering 2020-02-13 to 2022-03-08. Get the full timeline:

Most recent: Clinical Trial Update: HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors [Phase 1, Phase 2]

See pricing